Neurogenic inflammation, the pathogenesis of many diseases

OLYS Pharma is developing a technology platform, protected by patents, capable of breaking the vicious pro-inflammatory cycle of neurogenic inflammation, considered the pathogenesis of many diseases. This is a significant breakthrough for the hundreds of millions of patients with conditions causing chronic inflammatory pain.